Core Promoter Mutation of ntC1731T and G1806A of Hepatitis B Virus Increases HBV Gene Expression |
Cho, Ja Young
(Biotechnology Research Division, National Institute of Fisheries Science)
Yi, Yi Kyaw (Advanced Molecular Research Centre, Department of Medical Research) Seong, Mi So (Department of Molecular Biology, Pusan National University) Cheong, JaeHun (Department of Molecular Biology, Pusan National University) |
1 | Lopez-Cabrera, M., Letovsky, J., Hu, K. Q. and Siddiqui, A. 1991. Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus. Virology 183, 825-829. DOI |
2 | Moriyama, K., Okamoto, H., Tsuda, F. and Mayumi, M. 1996. Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. Virology 226, 269-280. DOI |
3 | Conjeevaram, H. S. and Lok, A. S. 2003. Management of chronic heaptitis B. J. Hepatol. 38, 90-103. DOI |
4 | Tsai, A., Kawai, S., Kwei, K. Gewaily, D., Hutter, A., Tong, D. R., Li, J., Wands, J. R. and Tong, S. 2009. Chimeric constructs between two hepatitis B virus genomes confirm transcriptional impact of core promoter mutations and reveal multiple effects of core gene mutations. Virology 387, 364-372. DOI |
5 | Wang, J., Huang, H., Liu, Y., Chen, R., Yan, Y., Shi, S., Xi, J., Zou, J., Yu, G., Feng, X. and Lu, F. 2020. HBV genome and life cycle. Adv. Exp. Med. Biol. 1179, 17-37. DOI |
6 | Zheng, Y., Li, J. and Ou, J. H. 2004. Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. J. Virol. 78, 6908-6914. DOI |
7 | Pollicino, T., Bellinghieri, L., Restuccia, A., Raffa, G., Musolino, C., Alibrandi, A., Teti, D. and Raimondo, G. 2013. Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. Virology 444, 317-328. DOI |
8 | Costa, R. H., Kalinichenko, V. V., Holterman, A. X. and Wang, X. 2003. Transcription factors in liver development, differentiation, and regeneration. Hepatology 38, 1331-1347. DOI |
9 | Kamijo, N., Matsumoto, A., Umemura, T., Shibata, S., Ichikawa, Y., Kimura, T., Komatsu, M. and Tanaka, E. 2015. Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion. World J. Gastroenterol. 21, 541-548. DOI |
10 | McMahon, B. J. 2009. The natural history of chronic hepatitis B virus infection. Hepatology 49, S45-55. DOI |
11 | Datta S. 2008. An overview of molecular epidemiology of hepatitis B virus (HBV) in india. Virol. J. 5, 156. DOI |
12 | Hunt, C. M., McGill, J. M., Allen, M. I. and Condreay, L. D. 2000. Clinical relevance of hepatitis B viral mutations. Hepatology 31, 1037-1044. DOI |
13 | Poli, V. 1998. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 273, 29279-29282. DOI |
14 | Scaglioni, P. P., Melegari, M. and Wands, J. R. 1997. Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology 233, 374-381. DOI |
15 | Wu, J. F. and Chang, M. H. 2015. Natural history of chronic hepatitis B virus infection from infancy to adult life-the mechanism of inflammation triggering and long-term impacts. J. Biomed. Sci. 22, 92. DOI |
16 | Quarleri, J. 2014. Core promoter: a critical region where the hepatitis B virus makes decisions. World J. Gastroenterol. 20, 425-435. DOI |
17 | Buckwold, V. E., Xu, Z., Chen, M., Yen, T. S. and Ou, J. H. 1996. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J. Virol. 70, 5845-5851. DOI |
18 | Chang, M. H. 2007. Hepatitis B virus infection. Semin. Fetal Neonatal Med. 12, 160-167. DOI |
19 | Custer, B. 2004. Global epidemiology of hepatitis B virus. J. ClinGastroenterol. 38, S158-168. |
20 | Hsu, Y. S., Chien, R. N., Yeh, C. T., Sheen, I. S., Chiou, H. Y., Chu, C. M. and Liaw, Y. F. 2002. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35, 1522-1527. DOI |
21 | Block, T. M., Guo, H. and Guo, J. T. 2007. Molecular virology of hepatitis B virus for clinicians. Clin. Liver Dis. 11, 685-706. DOI |
22 | Kao, J. H., Wu, N. H., Chen, P. J., Lai, M. Y. and Chen, D. S. 2000. Hepatitis genotypes and the response to interferon therapy. J. Hepatol. 33, 998-1002. DOI |
23 | Chong, C. L., Chen, M. L., Wu, Y. C., Tsai, K. N., Huang, C. C., Hu, C. P., Jeng, K. S., Chou, Y. C. and Chang, C. 2011. Dynamics of HBV cccDNA expression and transcription in different cell growth phase. J. Biomed. Sci. 18, 96. DOI |
24 | Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T. and Kishimoto, T. 1990. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9, 1897-1906. DOI |
25 | Allweiss, L. and Dandri, M. 2017. The role of cccDNA in HBV maintenance. Viruses 9, 156. DOI |
26 | An, P., Xu, J., Yu, Y. and Winkler, C. A. 2018. Host and viral genetic variation in HBV-related hepatocellular carcinoma. Front. Genet. 9, 261. DOI |
27 | Beck, J. and Nassal, M. 2007. Hepatitis B virus replication. World J. Gastroenterol. 13, 48-64. DOI |
28 | Belyhun, Y., Liebert, U. G. and Maier, M. 2018. Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia. PLoS One 13, e0191970. DOI |
29 | Brunetto, M. R., Oliveri, F., Coco, B., Leandro, G., Colombatto, P., Gorin, J. M. and Bonino, F. 2002. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. J. Hepatol. 36, 263-270. |